The regulation of artificial intelligence (“AI”) in healthcare is, and will likely continue to be, in flux for the foreseeable future. A review of the U.S. regulatory landscape impacting AI reveals a patchwork of existing and emerging rules at both the state and Federal levels, variable definitions of AI, differing approaches with respect to regulation of AI development versus deployment, and a range of risks sought to be addressed. In addition, recent efforts by the Biden administration thr
...THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 18.97.14.89
Please verify email or join us to access premium content!